“It is not enough to focus on vaccine development and approvals. We must work in parallel to establish the infrastructure and partners with the strongest capabilities, like Maersk, to safely deliver our vaccine around the world,” said Hu Mei Mei, co-CEO of Covaxx.
Rob Townley said efficient and safe delivery of Covid-19 vaccines around the world is "the most urgent logistics challenge" currently being faced by the industry.
"AP Moller-Maersk is committed to working closely with Covaxx to ensure smooth end-to-end global delivery of this vaccine as soon as it becomes available."
The partnership agreement provides for the end-to-end supply chain management, packing and shipping, via air or ocean, ground transportation, warehouse storage and distribution to facilities to support Covaxx’s requirements for a pharmaceutical grade, temperature-controlled supply chain.
The design of the vaccine components will allow for the use of existing cold-chain storage and distribution channels, as the Covaxx vaccine is anticipated not to require additional infrastructures such as the -80 degrees Celsius freezers seen for other vaccines or liquid nitrogen tanks to store materials at extreme temperatures.